Comparing diet education and routine care on preventive indices of cardiovascular disease in patients with rheumatoid arthritis

Effects of diet education on preventive indices of cardiovascular disease in patients with rheumatoid arthritis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017090314251N6

Enrollment

Registered

2017-10-02

Start date

2017-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of diet education on preventive indices of cardiovascular disease in patients with rheumatoid arthritis. Lipoprotein deficiency

Interventions

Intervention 1: Patients in intervention group will receive education in 4 sessions with 80 minutes duration during 4 weeks. Intervention 2: Patients in control group will receive no education and onl

Prevention

Patients in intervention group will receive education in 4 sessions with 80 minutes duration during 4 weeks.

Patients in control group will receive no education and only will receive routine care.

Eligibility

Sex/Gender

All

Age

29 Years to 59 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age of 30-60 years; diagnosis of rheumatoid arthritis at least for 6 months; being able to speak in Persian; having reading and writing capability. Exclusion criteria: having diabetes mellitus, hypertension, thyroid disorders, renal failure, blood lipids disorders, Cushing syndrome, hepatitis and cancer; being pregnant; lack of having regular diet.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total blood cholesterol level. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit with auto-analyzer system.;Triglyceride blood level. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit with auto-analyzer system.;Rheumatoid factor. Timepoint: Before and after intervention. Method of measurement: By ELISA method using anti-Rheumatoid factor kt of Abcam system.;Lipoprotein. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit with auto-analyzer system.;Body mass index. Timepoint: Before and after intervention. Method of measurement: Researcher-made questionnaire.;Hemoglobin A1c. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit.;Blood pressure. Timepoint: Before and after intervention. Method of measurement: Standard sphygmomanometer.;Urine albumin index. Timepoint: Before and after intervention. Method of measurement: By ELISA method using kit of Orgentec Diagnostika system.	—

Measure

Time frame

Total blood cholesterol level. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit with auto-analyzer system.;Triglyceride blood level. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit with auto-analyzer system.;Rheumatoid factor. Timepoint: Before and after intervention. Method of measurement: By ELISA method using anti-Rheumatoid factor kt of Abcam system.;Lipoprotein. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit with auto-analyzer system.;Body mass index. Timepoint: Before and after intervention. Method of measurement: Researcher-made questionnaire.;Hemoglobin A1c. Timepoint: Before and after intervention. Method of measurement: Pars Azmoon kit.;Blood pressure. Timepoint: Before and after intervention. Method of measurement: Standard sphygmomanometer.;Urine albumin index. Timepoint: Before and after intervention. Method of measurement: By ELISA method using kit of Orgentec Diagnostika system.

—

Secondary

Measure	Time frame
Diet status. Timepoint: Before and after intervention. Method of measurement: Food frequency questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRahil Taheri

Ahvaz Jundishapur University of Medical Sciences

Rahiltaheri@hotmail.com+98 61 3373 8255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026